SMASH-HCM, an initiative focused on transforming the landscape of Hypertrophic Cardiomyopathy (HCM). Our project aims to develop a cutting-edge digital-twin platform, integrating dynamic biophysical models and data-driven insights for personalized HCM stratification and improved disease management. Join us in advancing the state of the art in human digital-twins, delivering new insights, enhanced patient care, and a validated strategy through a pilot clinical trial.
Specifies decision-making processes and project-related bodies’ members
Data Management concepts established/ Data transfer agreements (DTA)
Risk and quality assessment. R-DMP for common standards for management of research data/Each partner signs DTA
PSC lines shared
CMR data available
API for is available for use in software solution
Initial calibrated populations available
Framework description
Lines generated
Report on HCM population of smooth muscle cell models
Multi-scale methods to simulate phenotypic genetic variants in HCM and Pipeline for the personalization of human heart electromechanical models
Report and validation results of HCM risk stratification/clustering model
Final version of the DSS, ready for pilot validation study/ Discussions with FIMEA and DEKRA representatives performed
Discussions with patient org representative and subgroups performed , Representatives of pharmaceutical and technological industry discussed with SMASH-HCM consortium
Pipeline for integrated multi-organ model of integrating cardiovascular
and autonomic nervous systems. Patient-specific multi-organ models
Predictions shared
Prognostics of personalized optimal therapy choices based on clinical outcome
A recent study published in the International Journal of Cardiology highlights innovative findings on ventricular arrhythmias (VA) risk profiles in hypertrophic cardiomyopathy (HCM). The study, led by a research team…
On May 15th, 2024, the SMASH-HCM project team met with patient organisations from the United Kingdom, Ireland, Finland, and Italy to discuss our innovative approach to improving the stratification and…
Thrilled to announce the kick-off of the SMASH-HCM project! Hypertrophic Cardiomyopathy (HCM), a common inherited heart disease, presents diverse risks but is currently diagnosed and treated as a single condition….